Daniela Kandioler Univ.Prof. Dr. Daniela Kandioler, MBA

International delegate, PR-Medienreferentin

Medical University of Vienna –
General Hospital Department of Surgery
Waehringer Guertel 18-20
A-1090 Vienna, Austria

Phone: +43 1 40400 5621
Fax: +43 1 40400 5447

E-mail: Daniela.Kandioler@meduniwien.ac.at
Internet: www.p53.at , www.kandioler.at


CURRICULUM VITAE
Born 1967 Vienna, Austria
Employed

Professor for General Surgery
Thoracic & Vascular Surgery and Intensive Care Medicine;
Department of Surgery, Medical University of Vienna, Austria
Postal address

Medical University of Vienna
Department of Surgery
Waehringer Guertel 18-20
A-1090 Vienna, AUSTRIA
Phone  
Email
Web

0043 1 40400 5621
Daniela.Kandioler@meduniwien.ac.at
www.Kandioler.at, www.p53.at
Ordination: Saarplatz 3, A-1190 Vienna
Phone: 0043 1 32 89 554
Email ordination@kandioler.at
Education:
  • 1991-92
    Thesis: Posttransplant Lymphoproliferative diseases; University of Vienna
  • 1992 July
    MD, University of Vienna Medical School
  • 2002 Oct
    Professor General Surgery
  • 2004 April
    Specialization Vascular Surgery
  • 2006 Dec
    MBA Health Management
  • 2008 July
    Specialization Thoracic Surgery
  • 2014 Oct
    Specialization Intensive Care Medicine
Professional History
  • 1992-1994 
    Residencies in Molecular Biology ,University of Vienna, Royal Marsden Hospital London Imperial College, University of Berlin Steglitz
  • 1992
    Experimental video assisted thoracic surgery, Cincinnati Ohio and Norwalk Connecticut
Organization International Meetings
  • 1996
    Secretary 2nd Joint Meeting Societies of Thoracici and Cardiovascular Surgery, Germany, Switzerland and Austria
  • 2009
    President ASSO Annual congress; Individualized cancer therapy
Awards
  • 1999 Theodor Billroth Prize
  • 1999 VFWF Prize
Sponsored academic trials
  • 2004
    Prospective pahse II study; p53 adapted induction chemotherapy in NSCLC (EK 140/2004)
  • 2011
    Prospective phase II study; PART p53 adapted radiation therapy in rectal cancer (EK 568/2011)
  • Ongoing
    PANCHO – prospective randomized phase III biomarker trial, esophageal cancer (NCT 00525200, EK 128/2007)
Editor
  • 2011
    ACO Manual of Surgical Cancer Therapy, ISBN 978-3-901299-60-5, Verlag Krause&Pachernegg GmbH
  • Editor in chief
    2009-2011
    Journal: Interdisziplinäre Onkologie      
Research
  • 1993-1994
    Equipping molecular genetic laoratory unit, Surgical research Laboratories, Medical University of Vienna
  • 1994
    Foundation p53 research group www.p53.at;  Head;
  • 1994-2016
    Impact factor IF 310,29
  • 1993-2016
    Research funding  € 1.297.000
  • 2013
    Biomarker start up Foundation, CEO; mark53.com
  • 2016
    Patents granted 2
Doctoral students
  • Mag Carmen Ludwig
    P53 status and response to neoadjuvant therapy in breast cancer
  • DI Kappel Sonja
    Genetic tumor profiling using the p53 tumor suppressor gene as diagnostic and predictive marker
Diploma students
  • Nina Pilat
    P53 gene analysis for prediction of response to chemotherapy  in CRCLM patients
Journal reviewing
  • Molecular Oncology
  • Eur J Surg Oncology
  • British Journal of Cancer, Clinical Chemistry
  • Transplant International
  • European Surgery
  • Bio MEd Central
  • Eur J Surg Oncology
  • Memo
Board Member:
  • Austrian Societey of Surgical Oncology (ASSO)
  • European Federation of Rectal cancer (EFR)
  • World Organization for Specialized studies in diseases of the esophagus (OESO)
  • European Society for Surgical Oncology (ESSO)

 

 

Top
MENU